SEC Company Response from ELITE PHARMACEUTICALS (ELTP) — Oct 7, 2015

ELITE PHARMACEUTICALS INC /NV/ (ELTP) (CIK 0001053369)
Date: Oct. 7, 2015 · CIK: 0001053369 · Accession: 0001144204-15-058411

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-15697

Date

October 7, 2015

Author

s/Carter Ward

Form

CORRESP

Company

ELITE PHARMACEUTICALS INC /NV/ (ELTP) (CIK 0001053369)

Letter

Securities and Exchange Commission Filed June 15, 2015 Form 10-Q for the Quarterly Period Ended June 30, 2015 Filed August 10, 2014 File No. 001-15697

Re: Elite Pharmaceuticals, Inc.

Dear Mr. Rosenberg:

Elite Pharmaceuticals, Inc. hereby acknowledges receipt of the September 25, 2015 SEC Comment Letter regarding the above referenced periodic reports (the “Letter”).

As we are in the midst of closing the most recent quarter and preparing the requisite Form 10-Q and will need additional time to respond to the comments in the Letter, we hereby request that our time to respond to the Letter be extended to October 26, 2015, 20 business days after the date of the Letter. At this time, we anticipate that we will be able to respond to the Letter on or before the requested extension date.

If you have any questions or comments or are unable to so extend our time to respond, please contact the undersigned at the above address.

Very truly yours,
s/Carter Ward

Show Raw Text

CORRESP
1
filename1.htm

October 7, 2015

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Jim B. Rosenberg

    Re:
    Elite Pharmaceuticals, Inc.

    Form 10-K for the Fiscal Year Ended March 31, 2015

    Filed June 15, 2015

    Form 10-Q for the Quarterly Period Ended June 30, 2015

    Filed August 10, 2014

    File No. 001-15697

Dear Mr. Rosenberg:

Elite Pharmaceuticals, Inc. hereby acknowledges
receipt of the September 25, 2015 SEC Comment Letter regarding the above referenced periodic reports (the “Letter”).

As we are in the midst of closing the most
recent quarter and preparing the requisite Form 10-Q and will need additional time to respond to the comments in the Letter, we
hereby request that our time to respond to the Letter be extended to October 26, 2015, 20 business days after the date of the Letter.
At this time, we anticipate that we will be able to respond to the Letter on or before the requested extension date.

If you have any questions or comments or
are unable to so extend our time to respond, please contact the undersigned at the above address.

    Very truly yours,

    s/Carter Ward

    Carter Ward, CFO

SecProbe.io